CD8A and type 1 diabetes mellitus: This role is also supported by several studies showing that (1) in vivo treatment with anti-CD4 prevents spontaneous T1D; (2) splenic CD4+ and CD8+ T cells from diabetic NOD mice can transfer the disease and; (3) neonatal thymectomy prevents T1D onset [3].